Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Vicente Soriano, Víctor Moreno-Torres, Ana Treviño, Pablo Barreiro, Fernando de Jesus, Octavio Corral & Carmen de Mendoza. (2023) Safety considerations in the management of hepatitis C and HIV co-infection. Expert Opinion on Drug Safety 22:5, pages 363-372.
Read now
Read now
Sara I. Aboras, Heba H. Abdine, Marwa A. A. Ragab & Mohamed A. Korany. (2022) A Review on Analytical Strategies for the Assessment of Recently Approved Direct Acting Antiviral Drugs. Critical Reviews in Analytical Chemistry 52:8, pages 1878-1900.
Read now
Read now
Ildiko Lingvay, Nadine Beetz, Regina Sennewald, Annette Schuler-Metz, Julia Bertulis, Christina Loley, Benjamin Lang, Caroline Lippert, Jisoo Lee, Linda Shapiro Manning & Derek Terada. (2020) Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes. Postgraduate Medicine 132:4, pages 337-345.
Read now
Read now
Articles from other publishers (9)
Michael Murray. (2023) Mechanisms and Clinical Significance of Pharmacokinetic Drug Interactions Mediated by FDA and EMA-approved Hepatitis C Direct-Acting Antiviral Agents. Clinical Pharmacokinetics 62:10, pages 1365-1392.
Crossref
Crossref
Rishitha Gundala, Himani Balutia, R. Lavanya, Ravichandiran Velayutham & Kuldeep K. Roy. 2020. Cancer-Leading Proteases. Cancer-Leading Proteases
243
263
.
Hadas Dvory‐Sobol, Bin Han, Julia Lu, Mei Yu, Rudolf K. Beran, Guofeng Cheng, Ross Martin, Evguenia Svarovskaia & Hongmei Mo. (2019) In vitro resistance profile of hepatitis C virus NS5A inhibitor velpatasvir in genotypes 1 to 6. Journal of Viral Hepatitis.
Crossref
Crossref
Hwa-Ping Feng, Luzelena Caro, Christine Fandozzi, Xiaoyan Chu, Zifang Guo, Jennifer Talaty, Deborah Panebianco, Katherine Dunnington, Lihong Du, William D. Hanley, Iain P. Fraser, Anna Mitselos, Jean-Francois Denef, Inge De Lepeleire, Jan N. de Hoon, Corinne Vandermeulen, William L. Marshall, Patricia Jumes, Xiaobi Huang, Monika Martinho, Robert Valesky, Joan R. Butterton, Marian Iwamoto & Wendy W. Yeh. (2019) Pharmacokinetic Interactions between the Hepatitis C Virus Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, and Darunavir in Healthy Volunteers. Antimicrobial Agents and Chemotherapy 63:4.
Crossref
Crossref
Gema Lledó, Laura Benítez-Gutiérrez, Ana Arias, Silvia Requena, Valentín Cuervas-Mons & Carmen de Mendoza. (2019) Benefits of hepatitis C cure with antivirals: why test and treat?. Future Microbiology 14:5, pages 425-435.
Crossref
Crossref
Ada Bertoli, Maria Chiara Sorbo, Marianna Aragri, Ilaria Lenci, Elisabetta Teti, Ennio Polilli, Velia Chiara Di Maio, Laura Gianserra, Elisa Biliotti, Chiara Masetti, Carlo F. Magni, Sergio Babudieri, Laura A. Nicolini, Martina Milana, Pierluigi Cacciatore, Loredana Sarmati, Adriano Pellicelli, Stefania Paolucci, Antonio Craxì, Filomena Morisco, Valeria Pace Palitti, Massimo Siciliano, Nicola Coppola, Nerio Iapadre, Massimo Puoti, Giuliano Rizzardini, Gloria Taliani, Caterina Pasquazzi, Massimo Andreoni, Giustino Parruti, Mario Angelico, Carlo Federico Perno, Valeria Cento, Francesca Ceccherini-Silberstein, Pietro Andreone, Fausto Baldanti, Giorgio Barbarini, Vincenzo Boccaccio, Lucio Boglione, Matteo Bolis, Stefano Bonora, Vanni Borghi, Giuseppina Brancaccio, Savino Bruno, Bianca Bruzzone, Vincenza Calvaruso, Nicola Caporaso, Antonio Ciaccio, Alessia Ciancio, Piero Colombatto, Raffaele Cozzolongo, Cecilia D’Ambrosio, Gabriella D’Ettorre, Francesco De Leonardis, Andrea De Luca, Antonio Di Biagio, Giovanni Di Perri, Simona Francioso, Giovanni Battista Gaeta, Antonio Gasbarrini, Valeria Ghisetti, Alessia Giorgini, Antonio Grieco, Guido Gubertini, Roberto Gulminetti, Lara Lambiase, Simona Landonio, Miriam Lichtner, Ivana Maida, Simona Marenco, Letizia Marinaro, Renato Maserati, Michela Melis, Barbara Menzaghi, Elisa Meregalli, Valeria Micheli, Fosca Niero, Maurizio Paoloni, Alessandro Pieri, Maria Rendina, Dante Romagnoli, Barbara Rossetti, Tina Ruggiero, Vincenzo Sangiovanni, Mario Starace, Laura Sticchi, Pierluigi Tarquini, Pierluigi Toniutto, Vincenzo Vullo & Maurizio Zazzi. (2018) Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1–4 in Italy. Scientific Reports 8:1.
Crossref
Crossref
Andrew J. McArdle, Anna Turkova & Aubrey J. Cunnington. (2018) When do co-infections matter?. Current Opinion in Infectious Diseases 31:3, pages 209-215.
Crossref
Crossref
Young-A Heo & Emma D. Deeks. (2018) Sofosbuvir/Velpatasvir/Voxilaprevir: A Review in Chronic Hepatitis C. Drugs 78:5, pages 577-587.
Crossref
Crossref
Massimo Andreoni, Sergio Babudieri, Savino Bruno, Massimo Colombo, Anna L. Zignego, Vito Di Marco, Giovanni Di Perri, Carlo F. Perno, Massimo Puoti, Gloria Taliani, Erica Villa & Antonio Craxì. (2017) Current and future challenges in HCV: insights from an Italian experts panel. Infection 46:2, pages 147-163.
Crossref
Crossref